BIOTECHNOLOGY LETTERS is a prestigious peer-reviewed journal that has been at the forefront of biotechnology research since its inception in 1979. Published by Springer, this esteemed journal serves as a vital platform for disseminating cutting-edge research in the fields of applied microbiology, bioengineering, and biotechnology, with a focus on innovative methodologies and technologies. With an impact factor reflecting its critical contribution to the discipline, BIOTECHNOLOGY LETTERS resides in the Q2 and Q3 tiers of various scientific categories, placing it among the notable journals in the biotechnological landscape. Although it offers traditional access options and does not feature open access, the journal embraces a global readership, encouraging submissions from researchers, professionals, and students eager to explore the dynamic advancements in biotechnology. Situated in the Netherlands, it continues to shape the future of the field through relevant, impactful research that addresses contemporary challenges and opportunities in medicine and beyond.

BIOLOGICAL RESEARCH is a prestigious, peer-reviewed journal published by the Société de Biologie de Chile, dedicated to advancing the fields of Agricultural and Biological Sciences, Biochemistry, Genetics, and Molecular Biology, and Medicine. With an impressive ranking in the top quartile (Q1) in these categories as of 2023, this journal maintains high academic standards and visibility, making it a vital resource for researchers and professionals alike. Operating under an Open Access model since 2013, it ensures that research findings are freely accessible to a global audience, promoting the dissemination of knowledge and collaboration across disciplines. With a publication history dating back to 1992 and continued updates until 2024, BIOLOGICAL RESEARCH serves as a crucial platform for innovative research that impacts both scientific and healthcare communities. The journal’s commitment to quality and relevance is evidenced by its competitive performance in Scopus rankings, further solidifying its role as a leading journal within the biological sciences.

CRITICAL REVIEWS IN BIOTECHNOLOGY, published by Taylor & Francis Ltd, stands as a leading journal in the field of biotechnology, consistently recognized for its rigorous peer-reviewed articles that impact the disciplines of Applied Microbiology, Biotechnology, and Medicine. With an impressive Q1 ranking in these categories and a significant influence reflected in its Scopus rankings—placing it within the top 5% of Applied Microbiology and the top 4% of Biotechnology journals—the journal serves as an essential resource for researchers, professionals, and students alike. Launched in 1983 and extending its coverage to encompass groundbreaking findings through 2024, it provides a rich forum for insightful reviews and innovative research that propel the field forward. Though not an Open Access journal, CRITICAL REVIEWS IN BIOTECHNOLOGY remains a vital point of reference for ongoing developments, critical analyses, and emerging trends, making it indispensable for those seeking to stay at the forefront of biotechnological advancements.

Applied Microbiology and Biotechnology, an esteemed journal published by Springer, serves as a vital resource in the domains of microbiology and biotechnology. With an impressive impact factor reflecting its quality, the journal holds Q1 rankings in various categories including Applied Microbiology and Biotechnology, Biotechnology, and Medicine (Miscellaneous) as of 2023. Spanning the years from 1984 to 2024, it underscores its commitment to disseminating groundbreaking research that addresses pressing challenges in health, agriculture, and environmental sustainability. The journal is rigorously indexed and holds respectable positions in Scopus rankings, notably within the top 15% of Applied Microbiology and Biotechnology and the top 15% in Biochemistry, Genetics, and Molecular Biology. Although it is not Open Access, its comprehensive articles, reviews, and short communications are indispensable for researchers, professionals, and students eager to advance their understanding and application of microbial processes and biotechnological innovations in real-world contexts.

AMB Express is an esteemed open-access journal published by Springer, dedicated to the fields of Applied Microbiology and Biotechnology as well as Biophysics. Since its inception in 2011, the journal has played a pivotal role in disseminating cutting-edge research and advancements, particularly for the scientific community in Germany and beyond. With a notable impact factor and ranking in the top quartile of its categories, AMB Express is recognized for its contributions to the disciplines, ranking 29th in Biochemistry, Genetics and Molecular Biology and 37th in Applied Microbiology and Biotechnology, reflecting its commitment to high-quality scientific inquiry. Researchers, professionals, and students will find a wealth of knowledge within its pages, benefiting from a diverse array of articles that stimulate innovation and collaboration. As the journal continues its convergence from 2011 to 2024, it remains a vital source for anybody looking to stay at the forefront of microbiological and biotechnological studies.

Bioengineered, published by TAYLOR & FRANCIS INC, is an esteemed Open Access journal that has been at the forefront of research in the fields of bioengineering, biotechnology, and applied microbiology since its inception in 2012. With an impressive impact factor reflecting its high-quality contributions, the journal is categorized in the top quartiles, achieving Q1 rankings in Applied Microbiology and Biotechnology, as well as in Biotechnology and Medicine (Miscellaneous) for 2023. This active engagement in showcasing pioneering research is critical for professionals and students alike, facilitating access to revolutionary studies and methodologies. The journal operates under an Open Access model since 2018, ensuring that groundbreaking findings in bioengineering are readily accessible to a global audience. Situated in the United Kingdom, Bioengineered not only serves as a platform for innovative research but also underscores the importance of interdisciplinary collaborations among scientists, engineers, and biotechnologists.

PREPARATIVE BIOCHEMISTRY & BIOTECHNOLOGY, published by Taylor & Francis Inc, serves as a vital platform for advancing research in the fields of biochemistry, biotechnology, and related areas of medicine. With an ISSN of 1082-6068 and an E-ISSN of 1532-2297, this journal has established itself with a notable Q3 ranking in the 2023 categories of Biochemistry, Biotechnology, and Miscellaneous Medicine, reflecting its relevance and contribution to these disciplines. The journal encompasses a wide range of topics, providing crucial insights into preparative methods, innovative biotechnological applications, and their implications for various medical advancements. Although not open access, the journal's rich content is crucial for researchers and professionals aiming to stay abreast of the latest developments and methodologies in biochemistry and biotechnology. With an enduring commitment to excellence since its inception in 1996, the journal remains an essential resource for academics and practitioners dedicated to advancing scientific knowledge and practical applications.

Current Research in Biotechnology is a leading journal published by Elsevier, dedicated to the dissemination of high-quality research in the rapidly evolving field of biotechnology. With an ISSN of 2590-2628, this journal has garnered a reputation for its insightful contributions, currently holding a prestigious Q2 ranking in the Biotechnology category, and placing in the 66th percentile within the Scopus rankings for Biochemistry, Genetics, and Molecular Biology. Running from 2019 and set to continue through 2024, the journal aims to provide a platform for groundbreaking studies that advance our understanding and application of biotechnological innovations. Although it operates under a subscription model, the journal ensures that research impacts a wide audience, facilitating collaboration among researchers, professionals, and students across the globe. By focusing on a diverse range of topics within biotechnology, Current Research in Biotechnology is committed to cultivating a vibrant discourse and fostering advancements that address critical challenges in health, agriculture, and environmental sustainability.

JOURNAL OF BIOTECHNOLOGY, published by Elsevier, stands as a premier platform in the fields of Applied Microbiology, Biotechnology, Bioengineering, and Medicine. With an ISSN of 0168-1656 and an E-ISSN of 1873-4863, this journal has significantly contributed to the advancement of biotechnological research since its inception in 1984 and continues to be a vital resource until 2024. Notably ranked in the Q2 quartile across multiple categories, it excels with impressive Scopus rankings, placing within the top 20% in Applied Microbiology and Biotechnology. This underscores its impact on both the scientific community and the ongoing developments in biotechnological applications. The journal encourages submissions that promote innovative research and practical insights, fostering collaboration among researchers, professionals, and students alike. Although it does not currently offer Open Access options, the journal remains highly regarded for its rigorous peer-review process and commitment to excellence in biotechnological literature.

The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.